Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pham

Showing results (261-270 of 322) with videos related to

Pageof 33
Sort By:
Brain : a Journal of Neurology|October 28, 2025
IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathologyGianvito Masi, Kangzhi Chen, Alexandra C Bayer, et al.
European Heart Journal. Cardiovascular Imaging|February 28, 2019
Normal values of aortic dimensions assessed by multidetector computed tomography in the Copenhagen General Population StudyMichael H C Pham, Christian Ballegaard, Martina C de Knegt, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusionsMaria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
Nature|November 8, 2016
RIPK1 inhibits ZBP1-driven necroptosis during developmentKim Newton, Katherine E Wickliffe, Allie Maltzman, et al.
Angewandte Chemie (International Ed. in English)|June 21, 2018
Terminal Hydride Species in [FeFe]-Hydrogenases Are Vibrationally Coupled to the Active Site EnvironmentCindy C Pham, David W Mulder, Vladimir Pelmenschikov, et al.
Diabetes Care|February 16, 2019
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR<sub>Rx</sub> Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin TherapyErin S Morgan, Li-Jung Tai, Nguyen C Pham, et al.
International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
European Heart Journal. Cardiovascular Imaging|October 17, 2018
Relationship between patient presentation and morphology of coronary atherosclerosis by quantitative multidetector computed tomographyMartina C de Knegt, Jesper J Linde, Andreas Fuchs, et al.
Pageof 33

Showing results (261-270 of 322) with videos related to

Sort By:
Pageof 33
Brain : a Journal of Neurology|October 28, 2025
IgA autoantibodies demonstrate a novel mechanism of MuSK myasthenia gravis pathologyGianvito Masi, Kangzhi Chen, Alexandra C Bayer, et al.
European Heart Journal. Cardiovascular Imaging|February 28, 2019
Normal values of aortic dimensions assessed by multidetector computed tomography in the Copenhagen General Population StudyMichael H C Pham, Christian Ballegaard, Martina C de Knegt, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusionsMaria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 20, 2022
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 TrialBradford S Hoppe, Romaine C Nichols, Stella Flampouri, et al.
Acta Oncologica (Stockholm, Sweden)|January 19, 2019
Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapyHe J Zhu, Romaine C Nichols, Randal H Henderson, et al.
Nature|November 8, 2016
RIPK1 inhibits ZBP1-driven necroptosis during developmentKim Newton, Katherine E Wickliffe, Allie Maltzman, et al.
Angewandte Chemie (International Ed. in English)|June 21, 2018
Terminal Hydride Species in [FeFe]-Hydrogenases Are Vibrationally Coupled to the Active Site EnvironmentCindy C Pham, David W Mulder, Vladimir Pelmenschikov, et al.
Diabetes Care|February 16, 2019
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR<sub>Rx</sub> Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin TherapyErin S Morgan, Li-Jung Tai, Nguyen C Pham, et al.
International Journal of Particle Therapy|December 4, 2020
Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 StudyShivam M Kharod, R Charles Nichols, Randal H Henderson, et al.
European Heart Journal. Cardiovascular Imaging|October 17, 2018
Relationship between patient presentation and morphology of coronary atherosclerosis by quantitative multidetector computed tomographyMartina C de Knegt, Jesper J Linde, Andreas Fuchs, et al.
Pageof 33